Navigation Links
LegalView Updates Avandia Information Portal With New Articles Detailing Potentially Dangerous Side Effects

LegalView continued to maintain its newsworthy coverage on its Avandia information portal with the recent addition of several new articles detailing the drug's potentially dangerous side effects. The type 2 diabetes drug has been linked to bone fracture, osteoporosis and heart failure among patients.

Denver, CO (PRWEB) January 27, 2009 --, the most comprehensive legal site available on the Internet, recently updated its Avandia information portal with new articles providing more detail and insight as to the potential Avandia side effects, which have been shown to range from the onset of osteoporosis to bone fractures among women as well as heart failure risks among all patients. Individuals who have recently consumed the drug and may be at risk for developing one of the drug's side effects should consider speaking with not only their medical professional, but an experienced pharmaceutical attorney as well, who can provide information on a potential Avandia lawsuit.

One of the new articles that can be found on the Avandia information portal details a treatment that can work to relieve one of the Avandia side effects. According to a New England Journal of Medicine article, Avandia patients are at an increased risk of developing heart failure; however, researchers may have discovered a technique in which heart failure victims are revived, and, with little side effects. The technique is that of therapeutic hypothermia and it occurs when a victim is cooled in order to avoid the onset of traumatic brain injury, which is often a side effect of a heart failure incident. Although the treatment offers a potential solution to one of the Avandia risks, it may still be necessary for a patient to receive a free legal consultation from an experienced Avandia lawyer.

In addition to providing continually updated news and information on all things Avandia, LegalView also offers details on a variety of other legal topics including the latest on the Fosamax dangers, the peanut butter recall and the cranial implant kit recall.

Fosamax is an osteoporosis drug from makers Merck and Company. Earlier this month, the drug was deemed dangerous by two separate medical publications for its Fosamax side effects, which include jaw bone die off and the potential onset of esophageal cancer. Patients who currently take the drug for bone density loss or osteoporosis should consider seeking medical attention immediately as it may be necessary to stop consumption of the drug.

LegalView has also been providing up-to-the minute news on the peanut butter recall, which has caused nearly 500 U.S. citizens to contract salmonella, seven of which have become fatal, according to multiple news reports. To learn more about the peanut butter recall, individuals are encouraged to obtain information at
One of the most potentially serious recalls to occur this year is that of Stryker Corporation's Custom Cranial Implant Kit recalls, which were recalled due to issues surrounding the sterility of the kits. If not surgically removed, a patient faces the potential for developing serious side effects as well as an increased risk of death. Patients who have received one of the 322 recalled cranial implant kits should speak with their surgeon immediately to determine the safest way to have the kits removed. Additionally, because of the severity of the side effects and the costs associated with having the kits recalled, it may be advisable for a patient to discuss the development of a cranial implant lawsuit with their attorney, as monetary compensation could be an outcome of such litigation.

About LegalView: is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin
2. LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients
3. LegalView Brain Injury Site Reports Department of Veteran Affairs Request for Research on TBI and Soldiers
4. LegalView Highlights Top Brain Injury Rehabilitation Hospitals in the United States - 5.3 Million Americans Suffer from TBI
5. LegalView Reports Details of War Veteran Brain Injuries Overlooked By Officials for Years
6. LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug
7. LegalView Re-launching Truck Accident Injury Information Portal with Updated News and Information on the Costly and Dangerous Accidents
8. LegalView Reports Cancer Risk for St. Louis Residents After Unapproved Asbestos Removal During Demolition
9. LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis
10. LegalView Reintroduces its Medical Malpractice Information Portal with Updated Links to Finding Immediate Legal Assistance
11. LegalView Re-Launches its Avandia Information Portal with News of the Type 2 Diabetes Drug's Risks and Dangers
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
(Date:11/25/2015)... ... November 25, 2015 , ... "When I ... regular bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. "In order ... developed the patent-pending RECOVERY BRA for added comfort and support. The bra is ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... on providing comprehensive solutions involving adult stem cell therapies to patients with chronic ... the “Regenestem” name as a Registered Trademark (RTM). , Organizations are required to ...
(Date:11/24/2015)... , ... November 24, 2015 , ... Dr. Todd S. ... offer laser services to many of his patients. Dr. Afferica now uses the BIOLASE ... reduce the amount of time the doctor uses other traditional cutting tools, such as ...
(Date:11/24/2015)... ... November 24, 2015 , ... In an article published ... that determine which patients are or are not eligible for bariatric surgery. The article ... over 40, are more than 100 pounds overweight, or have a BMI of 35 ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... , November 24, 2015 ... --> adds Latest Guidebook for ... of 217 pages published in November 2015 to ... online business intelligence library at . ... of the fastest growing global economies with a ...
(Date:11/24/2015)... 24, 2015  Ascendant Solutions, Inc. (Pink Sheets: ASDS ... of Directors has declared a special 1 percent stock dividend ... payable December 14, 2015, to shareholders of record December 7, ... additional shares of common stock. --> ... a strong endorsement of our confidence in Ascendant,s growth strategy ...
(Date:11/24/2015)... Nov. 24, 2015 Diplomat Pharmacy, Inc. (NYSE: DPLO) ... of Clinical Services, Education and Human Resources will be presenting ... Oncology Drugs: Health Plan Strategies for a Dynamic Market" on ... Fenrick , a consultant with the Cambridge Advisory Group, where ... The webinar will discuss the rapid growth ...
Breaking Medicine Technology: